Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome

The COVID-19 pandemics has caused the death of almost six million people worldwide. In order to establish collective immunity, the first vaccines that were approved in Germany were the vector virus-based vaccine Vaxzevria and the mRNA vaccines Comirnaty and Spikevax, respectively. As it was reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Thurm, Christoph, Reinhold, Annegret, Borucki, Katrin, Kahlfuss, Sascha, Feist, Eugen, Schreiber, Jens, Reinhold, Dirk, Schraven, Burkhart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880348/
https://www.ncbi.nlm.nih.gov/pubmed/35214790
http://dx.doi.org/10.3390/vaccines10020333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880348/
https://www.ncbi.nlm.nih.gov/pubmed/35214790
http://dx.doi.org/10.3390/vaccines10020333

Ejemplares similares